| p53 in breast cancer subtypes and new insights into response to chemotherapy P Bertheau, J Lehmann-Che, M Varna, A Dumay, B Poirot, R Porcher, ... The Breast 22, S27-S29, 2013 | 257 | 2013 |
| Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin−Cyclophosphamide Regimen P Bertheau, E Turpin, DS Rickman, M Espié, A De Reynies, JP Feugeas, ... PLoS medicine 4 (3), e90, 2007 | 208 | 2007 |
| TP53 Status and Response to Chemotherapy in Breast Cancer P Bertheau, M Espié, E Turpin, J Lehmann, LF Plassa, M Varna, A Janin, ... Pathobiology 75 (2), 132-139, 2008 | 151 | 2008 |
| Diffusion-weighted MRI in pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer R Richard, I Thomassin, M Chapellier, A Scemama, P de Cremoux, ... European radiology 23, 2420-2431, 2013 | 124 | 2013 |
| Advanced nanomedicines for the treatment of inflammatory diseases R Brusini, M Varna, P Couvreur Advanced drug delivery reviews 157, 161-178, 2020 | 122 | 2020 |
| TP53 status and response to treatment in breast cancers M Varna, G Bousquet, LF Plassa, P Bertheau, A Janin BioMed Research International 2011, 2011 | 108 | 2011 |
| Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents F Dormont, R Brusini, C Cailleau, F Reynaud, A Peramo, A Gendron, ... Science advances 6 (23), eaaz5466, 2020 | 98 | 2020 |
| Donor-derived oral squamous cell carcinoma after allogeneic bone marrow transplantation A Janin, H Murata, C Leboeuf, JM Cayuela, E Gluckman, L Legres, ... Blood, The Journal of the American Society of Hematology 113 (8), 1834-1840, 2009 | 77 | 2009 |
| In vivo Distribution of Inorganic Nanoparticles in Preclinical Models M Varna, P Ratajczak, I Ferreira, C Leboeuf, G Bousquet, A Janin Scientific Research Publishing, 2012 | 68 | 2012 |
| Immunohistochemical and molecular analyses of HER2 status in breast cancers are highly concordant and complementary approaches J Lehmann-Che, F Amira-Bouhidel, E Turpin, M Antoine, H Soliman, ... British journal of cancer 104 (11), 1739-1746, 2011 | 68 | 2011 |
| Gold nanoparticles in cardiovascular imaging M Varna, HV Xuan, E Fort Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 10 (1 …, 2018 | 64 | 2018 |
| Epithelial-to-mesenchymal transition and resistance to ingenol 3-angelate, a novel protein kinase C modulator, in colon cancer cells A Ghoul, M Serova, L Astorgues-Xerri, I Bieche, G Bousquet, M Varna, ... Cancer research 69 (10), 4260-4269, 2009 | 64 | 2009 |
| p53 dependent cell‐cycle arrest triggered by chemotherapy in xenografted breast tumors M Varna, J Lehmann‐Che, E Turpin, E Marangoni, M El‐Bouchtaoui, ... International journal of cancer 124 (4), 991-997, 2009 | 63 | 2009 |
| The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe Y Tao, C Leteur, J Calderaro, F Girdler, P Zhang, V Frascogna, M Varna, ... Cell Cycle 8 (19), 3172-3181, 2009 | 58 | 2009 |
| Stem cells increase in numbers in perinecrotic areas in human renal cancer M Varna, G Gapihan, JP Feugeas, P Ratajczak, S Tan, I Ferreira, ... Clinical cancer research 21 (4), 916-924, 2015 | 55 | 2015 |
| Induction of acquired drug resistance in endothelial cells and its involvement in anticancer therapy L Huang, C Perrault, J Coelho-Martins, C Hu, C Dulong, M Varna, J Liu, ... Journal of hematology & oncology 6, 1-12, 2013 | 51 | 2013 |
| Translation of nanomedicines from lab to industrial scale synthesis: The case of squalene-adenosine nanoparticles F Dormont, M Rouquette, C Mahatsekake, F Gobeaux, A Peramo, ... Journal of controlled release 307, 302-314, 2019 | 45 | 2019 |
| Nanoplumbers: biomaterials to fight cardiovascular diseases F Dormont, M Varna, P Couvreur Materials Today 21 (2), 122-143, 2018 | 45 | 2018 |
| Epstein–Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long‐term follow‐up L Verneuil, S Gouarin, F Comoz, F Agbalika, C Creveuil, M Varna, ... British Journal of Dermatology 163 (1), 174-182, 2010 | 41 | 2010 |
| Nanomedicine as a strategy to fight thrombotic diseases M Varna, M Juenet, R Bayles, M Mazighi, C Chauvierre, D Letourneur Future science OA 1 (4), 2015 | 40 | 2015 |
Didier LetourneurDR CNRS - INSERM U1148Adresse e-mail validée de inserm.fr
